Header Logo

Connection

Bruce Fireman to Pneumococcal Vaccines

This is a "connection" page, showing publications Bruce Fireman has written about Pneumococcal Vaccines.
Connection Strength

1.381
  1. Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine. 2006 Apr 12; 24 Suppl 2:S2-79-80.
    View in: PubMed
    Score: 0.256
  2. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004 Jun; 23(6):485-9.
    View in: PubMed
    Score: 0.225
  3. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003 Jan; 22(1):10-6.
    View in: PubMed
    Score: 0.204
  4. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065.
    View in: PubMed
    Score: 0.175
  5. Lack of association of Kawasaki disease after immunization in a cohort of infants followed for multiple autoimmune diagnoses in a large, phase-4 observational database safety study of 7-valent pneumococcal conjugate vaccine: lack of association between Kawasaki disease and seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2009 May; 28(5):438-40.
    View in: PubMed
    Score: 0.079
  6. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007 Sep; 26(9):771-7.
    View in: PubMed
    Score: 0.070
  7. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J. 2006 Sep; 25(9):779-81.
    View in: PubMed
    Score: 0.066
  8. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects. Pediatr Infect Dis J. 2006 Jun; 25(6):494-501.
    View in: PubMed
    Score: 0.065
  9. Pneumococcal conjugate vaccine in children. N Engl J Med. 2004 Jan 01; 350(1):84-5; author reply 84-5.
    View in: PubMed
    Score: 0.055
  10. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002 Sep; 21(9):810-5.
    View in: PubMed
    Score: 0.050
  11. Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2002 May; 21(5):361-5.
    View in: PubMed
    Score: 0.049
  12. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J. 2002 Mar; 21(3):182-6.
    View in: PubMed
    Score: 0.048
  13. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J. 1999 Sep; 18(9):757-63.
    View in: PubMed
    Score: 0.040

© 2024 Kaiser Permanente